Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Laboratory Animal Science|December 1, 1993
Echocardiographically detected myocardial infarction in the mouseW J Manning, J Y Wei, S E Katz, et al.
Circulation Research|September 5, 2001
Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failureK Ito, X Yan, X Feng, et al.
Environmental Pollution (Barking, Essex : 1987)|August 25, 2004
Assessing plant response to ambient ozone: growth of young apple trees in open-top chambers and corresponding ambient air plotsW J Manning, D R Cooley, A F Tuttle, et al.
The American Journal of Physiology|April 1, 1994
In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validationW J Manning, J Y Wei, S E Katz, et al.
Magnetic Resonance in Medicine|May 20, 1999
Signal-to-noise ratio and signal-to-noise efficiency in SMASH imagingD K Sodickson, M A Griswold, P M Jakob, et al.
Magnetic Resonance in Medicine|October 25, 2001
3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisitionR M Botnar, W Y Kim, P Börnert, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 12, 2001
Accelerated cardiac imaging using the SMASH techniqueP M Jakob, M A Griswold, R R Edelman, et al.
The American Journal of Cardiology|October 1, 1996
Evaluation of left atrial appendage anatomy and function in recent-onset atrial fibrillation by transesophageal echocardiographyD N Rubin, S E Katz, M F Riley, et al.
Annals of Internal Medicine|October 1, 1996
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study GroupR C Pasternak, L E Brown, P H Stone, et al.
The Annals of Thoracic Surgery|September 22, 2001
Predictors of conversion of atrial fibrillation after cardiac operation in the absence of class I or III antiarrhythmic medicationsR J Soucier, S Mirza, M G Abordo, et al.
Pageof 15